2026 · 2nd Quarter (Apr 1 - June 30)

TERUMO BCT, INC.

Filed by TERUMO BCT, INC..

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Aug 7, 2026
Income: Not reported
Expenses: $20,000.00
Registrant: TERUMO BCT, INC.
Client: TERUMO BCT, INC.
Filing UUID: 64970b56-3d11-41d9-9ac1-4731cda50294
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

TRD · Trade (domestic/foreign)

Global trade and tariffs

HCR · Health Issues

S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Blood and cell collection, storage, and processing Blood donation supply and quality

Literal federal measure citations: S.735, H.R. 1796

MMM · Medicare/Medicaid

Medicaid Eligibility, work and community engagement requirements

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.